CenExel highlights industry-leading capabilities amid growing FDA momentum advancing psychedelic clinical research

DRAPER, Utah, May 27, 2026 /PRNewswire/ -- The FDA recently announced it is shifting regulatory attention and investment for emerging psychedelic-based therapeutics treating mental health conditions. CenExel Clinical Research is answering this push with expansion to support psychedelic...